Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity
出版年份 2019 全文链接
标题
Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity
作者
关键词
-
出版物
ARTIFICIAL ORGANS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-08-07
DOI
10.1111/aor.13551
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy
- (2019) Mercè Brunet et al. THERAPEUTIC DRUG MONITORING
- The Cytochrome P450 3A5 Non-Expressor Kidney Allograft as a Risk Factor for Calcineurin Inhibitor Nephrotoxicity
- (2018) Suwasin Udomkarnjananun et al. AMERICAN JOURNAL OF NEPHROLOGY
- Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
- (2018) Julio Pascual et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
- (2018) Erlend Johannessen Egeland et al. TRANSPLANT INTERNATIONAL
- Comparison of sirolimus combined tacrolimus and mycophenolate mofetil combined tacrolimus in kidney transplantation recipients: a meta-analysis
- (2018) Leilei Gao et al. TRANSPLANTATION PROCEEDINGS
- Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis
- (2016) Evangelos Tsipotis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
- (2016) Thomas Vanhove et al. DRUG METABOLISM REVIEWS
- FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients
- (2016) Zhuo Wu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients
- (2016) J. Zegarska et al. TRANSPLANTATION PROCEEDINGS
- The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients
- (2015) Liang Ma et al. BMC IMMUNOLOGY
- Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients
- (2015) Nianqiao Gong et al. CELLULAR IMMUNOLOGY
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic variants of FOXP3 influence graft survival in kidney transplant patients
- (2013) Anja U. Engela et al. HUMAN IMMUNOLOGY
- Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation
- (2013) Tomohiro Tsuchiya et al. TRANSPLANTATION
- Acute Calcineurin Inhibitor Overdose: Analysis of Cases Reported to a National Poison Center Between 1995 and 2011
- (2012) A. Ceschi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo
- (2012) Kathrin Klein et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PharmGKB summary
- (2012) Jatinder Lamba et al. Pharmacogenetics and Genomics
- Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy
- (2011) R. Snanoudj et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Our evolving understanding of late kidney allograft failure
- (2011) Robert S. Gaston Current Opinion in Organ Transplantation
- Once- Versus Twice-Daily Tacrolimus
- (2011) Katherine A. Barraclough et al. DRUGS
- CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
- (2011) François Glowacki et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers
- (2011) Hui-Lin Tang et al. Pharmacogenetics and Genomics
- Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
- (2011) Laure Elens et al. PHARMACOGENOMICS
- Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation
- (2011) R. Calia et al. TRANSPLANTATION PROCEEDINGS
- Once Daily Tacrolimus Formulation: Monitoring of Plasma Levels, Graft Function, and Cardiovascular Risk Factors
- (2010) A. Meçule et al. TRANSPLANTATION PROCEEDINGS
- Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation
- (2009) H. Ekberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Calcineurin Inhibitor Nephrotoxicity
- (2009) M. Naesens et al. Clinical Journal of the American Society of Nephrology
- Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts
- (2009) M. Naesens et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Pharmacogenetic Strategy for Immunosuppression Based on the CYP3A5 Genotype
- (2009) Iain A. M. MacPhee et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now